LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China · Delayed Price · Currency is CNY 8.72
-0.20 (-2.24%)
Apr 9, 2026, 3:04 PM CST
SHE:002644 Revenue
In the year 2025, LanZhou Foci Pharmaceutical had annual revenue of 915.53M CNY, down -6.60%. LanZhou Foci Pharmaceutical had revenue of 291.48M in the quarter ending December 31, 2025, with 7.28% growth.
Revenue
915.53M
Revenue Growth
-6.60%
P/S Ratio
4.86
Revenue / Employee
672.20K
Employees
1,362
Market Cap
4.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 915.53M | -64.69M | -6.60% |
| Dec 31, 2024 | 980.23M | -182.91M | -15.73% |
| Dec 31, 2023 | 1.16B | 120.75M | 11.58% |
| Jan 1, 2023 | 1.04B | 224.75M | 27.49% |
| Jan 1, 2022 | 817.64M | 149.59M | 22.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.20B |
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Tibet Weixinkang Medicine | 1.17B |
| Shanghai Xiao Fang Pharmaceutical | 504.59M |